# Donepezil Double Blind Trial for ECT Memory Disfunction

> **NCT00465283** · PHASE4 · UNKNOWN · sponsor: **BeerYaakov Mental Health Center** · enrollment: 40 (estimated)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder
- Schizophreniform Disorder

## Interventions

- **DRUG:** Donepezil

## Key facts

- **NCT ID:** NCT00465283
- **Lead sponsor:** BeerYaakov Mental Health Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-05
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2009-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00465283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00465283, "Donepezil Double Blind Trial for ECT Memory Disfunction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00465283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*